Nachman Norwood & Parrott’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$433K Hold
2,771
0.04% 197
2021
Q1
$431K Sell
2,771
-256
-8% -$39.7K 0.05% 193
2020
Q4
$453K Sell
3,027
-153
-5% -$21.6K 0.05% 182
2020
Q3
$420K Sell
3,180
-27
-0.8% -$3.53K 0.06% 170
2020
Q2
$372K Sell
3,207
-35
-1% -$4.03K 0.06% 178
2020
Q1
$318K Sell
3,242
-28
-0.9% -$3.67K 0.06% 172
2019
Q4
$475K Buy
3,270
+66
+2% +$9.11K 0.08% 163
2019
Q3
$427K Sell
3,204
-13
-0.4% -$1.68K 0.08% 163
2019
Q2
$368K Buy
3,217
+188
+6% +$22K 0.07% 182
2019
Q1
$376K Buy
3,029
+39
+1% +$4.43K 0.07% 168
2018
Q4
$301K Buy
+2,990
New +$336K 0.06% 177

Other funds holding ZBH

Nachman Norwood & Parrott's ZBH Position: Q2 2021 in Review

Nachman Norwood & Parrott held its Zimmer Biomet (ZBH) position steady in Q2 2021 at 2,771 shares worth $433K. The position accounts for 0.04% of the portfolio, ranked #197.

Nachman Norwood & Parrott first reported a position in ZBH in Q4 2018 and has held it in 11 quarters since. The position peaked at $475K in Q4 2019. 1,019 funds tracked by Wall St. Rank hold ZBH as of Q2 2021.

  • Nachman Norwood & Parrott held 2,771 shares of Zimmer Biomet worth $433K as of Q2 2021.
  • Nachman Norwood & Parrott left its Zimmer Biomet share count unchanged in Q2 2021.
  • Zimmer Biomet made up 0.04% of Nachman Norwood & Parrott's portfolio in Q2 2021, its #197 holding.
  • Nachman Norwood & Parrott first reported a position in Zimmer Biomet in Q4 2018 and has held it in 11 quarters since.
  • Nachman Norwood & Parrott's Zimmer Biomet position peaked at $475K in Q4 2019.
  • 1,019 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2021.

Based on Nachman Norwood & Parrott's 13F filing for Q2 2021, filed 13 Aug 2021.